Lead Author, publication date
|
Mean time intervals from onset of symptoms (days) to DAIR
|
Time interval from index procedure. and DAIR (joint age)
|
Debridement Type
|
Exchange modular components N (%)
|
Use of rifampicin
|
Duration of antibiotic therapy (weeks)
|
Patient failed N (%)
|
Bacteria involved in failed cases
|
Surgical option for failed patients
|
Chiu et al. 2007,[@112019] |
Within 28 days |
28 – 72 months |
Open |
100% |
NA |
6 weeks IV at least |
5 (50%) |
NA |
Fusion or two-stage reimplantation. |
Choi et al. 2011,[@112024] |
Within 28 days |
0,5 – 240 months |
Open |
With or without PE exchange |
NA |
6 weeks IV |
16 (69%) |
S. aureus 16 (100%) |
Staged revision operation or repeated DAIR or fusion or amputation or resection. |
Estes et al. 2010,[@112006] |
Within 28 days |
NA |
Open
(two debridements + beads)
|
0%
(all modular components were removed and sterilized by flash autoclave or in a betadine soak)
|
26,6% |
6 weeks IV + 36 weeks OS |
2 (11%) |
MRSA 1 (50%)
S. agalactiae 1 (50%) |
None |
Fink et al. 2017,[@112023] |
1 - 21 |
NA |
Open |
100% |
100% |
2 weeks IV + variabile OS |
NA |
NA |
NA |
He et al. 2016,[@112003] |
2–7 |
7 – 61 months |
Open |
100% |
100% |
6 weeks IV + 12 weeks OS |
2 (19%) |
S. epidermidis 1 (50%)
S. aureus 1 (50%) |
1 Two-stage.
1 second implant removal prior to a second revision.
|
In jun Koh et al. 2015,[@112025] |
4–26 |
5 – 144 months |
Open |
94% |
NA |
6 weeks or less IV and then OS |
9 (45%) |
NA |
Multiple irrigation and debridement 1 (5%)
Suppression antibiotic therapy 1 (5%)
Two-stage revision 6 (30%)
Fusion or amputation 2 (10%)
|
Konigsberg et al. 2014,[@112012] |
1-28 |
6 – 186 months |
Open |
100% |
NA |
6 weeks IV |
NA |
Staphylococcus spp. |
Second debridement or
following implant removal and II stage reconstruction
including a medial gastrocnemius flap in one knee or
knee fusion or above knee
amputation.
|
Koyonos et al. 2011,[@112013] |
NA |
NA |
Open |
NA |
NA |
6 weeks IV |
NA |
NA |
NA |
Lora-Tamayo et al. 2017,[@112014] |
2–12 |
NA |
Open |
55% |
37% |
3 weeks IV |
NA |
NA |
NA |
Meehan et al. 2003,[@112015] |
1 – 9 |
1,8 – 138 months |
Open |
40% |
NA |
4 weeks IV + NA oral therapy.
42% of cases received long-term oral antimicrobial
therapy
|
0 (0%) |
None |
Patients underwent a median of one surgical
debridement (range, 1–3).
|
Mont et al. 1997,[@112016] |
3 - 28 |
6 – 71 months |
Open |
29% |
NA |
6 weeks IV |
4 (29%) |
S. aureus 1 (25%)
S. epidermidis 2 (50%)
E. coli 1 (25%)
|
Two-stage reimplantation or
second DAIR or knee fusion.
|
Segawa et al. 1999,[@112017] |
NA |
NA |
Open |
100% |
NA |
6 weeks IV |
2 (29%) |
NA |
1 Arthrodesis.
1 Suppressive antibiotic.
Both failed
|
Son et al. 2017,[@112018] |
1 - 5 |
NA |
Open |
100% |
Used when S. aureus was detected |
4 weeks IV |
3 (20%) |
MSSA 1 (33%)
Enterobacter 1 (33%)
Streptococcus spp. 1 (33%)
|
Second DAIR or
two-stage revisions.
|
Triantafyllopoulos et al. 2014,[@111996] |
2 – 60 |
95.3% occurred within
the first 365 days after index surgery
|
Open plus arthroscopy |
100% |
NA |
6 IV weeks + 6 weeks OS |
NA |
Staphylococcal spp (38%)
Other gram-positive bacteria (4%)
Gram negative bacteria (1%)
Negative cultures (1%)
|
II stage or second/third
DAIR or long-term suppression treatment with antibiotics.
|
Vilchez et al. 2011,[@112020] |
4,7 |
9 – 88 months |
Open |
100% |
100% |
1,5 week IV + 16 weeks OS |
7 (59%) |
Staphylococcus aureus resistant to fluoroquinolones 3 |
Second DAIR |
Zhang et al. 2016,[@111997] |
1 – 60 |
0 – 230 months |
Open |
NA |
NA |
4/6 weeks IV + 12/24 weeks OS |
11 (65%) |
Staphylococcus spp. and nonstaphylococcal spp. |
Two-stage revisions or
lifelong antibiotics suppression.
|